|Clinical Trial ID||NCT04169360|
|Lead Sponsor||University of Maryland, Baltimore|
|Status||Not yet recruiting|
This is a double blind, placebo controlled, randomized trial to evaluate the safety and preliminary efficacy of ANS-6637 in adults with opioid use disorder with and without opioid agonist therapy. Patients will be randomized to two arms: (1) ANS-6637 for three months vs (2) Placebo for three months. Subjects will subsequently be followed for an additional one month post treatment.
|Opioid-use Disorder||Drug: ANS-6637, Drug: Placebo oral tablet||Phase 2|
|Age||Gender||Accepts Healthy Volunteers|
|18 Years to 65 Years||All||No|